ULTRACET Drug Patent Profile
✉ Email this page to a colleague
When do Ultracet patents expire, and what generic alternatives are available?
Ultracet is a drug marketed by Janssen Pharms and is included in one NDA.
The generic ingredient in ULTRACET is acetaminophen; tramadol hydrochloride. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the acetaminophen; tramadol hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ULTRACET?
- What are the global sales for ULTRACET?
- What is Average Wholesale Price for ULTRACET?
Summary for ULTRACET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 26 |
| Drug Prices: | Drug price information for ULTRACET |
| What excipients (inactive ingredients) are in ULTRACET? | ULTRACET excipients list |
| DailyMed Link: | ULTRACET at DailyMed |
Recent Clinical Trials for ULTRACET
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Pfizer | Phase 4 |
| Gia Dinh People Hospital | N/A |
| The Catholic University of Korea | N/A |
US Patents and Regulatory Information for ULTRACET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | ULTRACET | acetaminophen; tramadol hydrochloride | TABLET;ORAL | 021123-001 | Aug 15, 2001 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ULTRACET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Pharms | ULTRACET | acetaminophen; tramadol hydrochloride | TABLET;ORAL | 021123-001 | Aug 15, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| Janssen Pharms | ULTRACET | acetaminophen; tramadol hydrochloride | TABLET;ORAL | 021123-001 | Aug 15, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ULTRACET
See the table below for patents covering ULTRACET around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Germany | 69226624 | ⤷ Sign Up | |
| China | 1071571 | ⤷ Sign Up | |
| Germany | 122004000032 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ULTRACET
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0566709 | SPC/GB04/012 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
| 0566709 | 300152 | Netherlands | ⤷ Sign Up | 300152, 20120903, EXPIRES: 20170404 |
| 0566709 | SPC023/2008 | Ireland | ⤷ Sign Up | SPC023/2008: 20090921, EXPIRES: 20170404 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
